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Abstract The assumption that reversible inhibition of mito-
chondrial respiration by nitric oxide (NOc) represents inhibition
of ATP synthesis is unproven. NOc could theoretically inhibit the
oxygen consumption with continued ATP synthesis, by acting as
an electron acceptor from cytochrome c or as a terminal electron
acceptor in stead of oxygen. We report here that NOc does
reversibly inhibit brain mitochondrial ATP synthesis with a time
course similar to its inhibition of respiration. Whilst such
inhibition was largely reversible, there appeared to be a small
irreversible component which may theoretically be due to
peroxynitrite formation, i.e. as a result of the reaction between
NOc and superoxide, generated by the mitochondrial respiratory
chain.
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1. Introduction
In early bioenergetic research, the interaction of molecules
such as nitric oxide (NOc) with the mitochondrial respiratory
chain proved useful in elucidating the molecular mechanism
of oxidative phosphorylation [1]. However, it was not until the
discovery that cells possess a family of NOc synthetic enzymes
[2] that such molecular interactions were considered to have
physiological relevance.
It is reported that NOc reversibly inhibits the mitochondrial
respiration in synaptosomes [3,4], skeletal muscle mitochon-
dria [5], brain mitochondria and sub-mitochondrial particles
[6], liver mitochondria [7,8], heart mitochondria [9,10] and
sub-mitochondrial particles [10] and cultured astrocytes [11].
In addition, NOc decreases membrane potential in liver mito-
chondria [8], ATP/ADP ratio in synaptosomes [4] and creatine
phosphate (PCr) NMR signal in intact beating guinea pig
heart [12].
The putative role of NOc as a physiological regulator of
cellular energy metabolism rests on the assumption that NOc
inhibition of mitochondrial oxygen consumption is represen-
tative for the inhibition of mitochondrial ATP synthesis.
However, there is no direct evidence for this. None of the
above studies examined mitochondrial ATP synthesis. The
observations that NOc reduces the ATP/ADP ratio in synap-
tosomes [3] and the PCr NMR signal in isolated guinea pig
heart [12], may be due to increased ATP consumption and not
necessarily due to a decreased ATP production by inhibited
mitochondria.
It is possible that NOc may act as a substitute electron
acceptor at cytochrome c oxidase (COX), or that NOc may
directly oxidise cytochrome c by passing COX. Thus, proton
pumping and ATP synthesis could continue despite a de-
creased oxygen consumption. It was therefore the aim of
this study to directly examine the e¡ects of NOc on ATP
synthesis in isolated brain mitochondria.
2. Materials and methods
All chemicals were of analytical grade from Sigma (Poole, Dorset,
UK) except Ficoll 400 which was from Amersham Pharmacia (Little
Chalfont, Buckinghamshire, UK) and cytochrome c from Roche
Products (Lewes, East Sussex, UK). NOc solution was prepared by
bubbling water (3 ml) with oxygen free N2 for 10 min, followed by
bubbling with NOc gas (Aldrich, Poole, Dorset, UK) for 15 min. The
resulting saturated solution was assumed to contain 1.9 mM NOc [13].
The solution was prepared fresh daily, kept sealed until use and re-
bubbled with NOc every 30 min throughout the experimental proce-
dures (1^2 h). Degraded NOc was prepared by leaving this solution
for 1 week with occasional agitation and opening to air.
Brain mitochondria were prepared from male rats of the Wistar
strain, 300^350 g in weight, as previously described [14]. Protein
was quanti¢ed by the method of Lowry et al. [15] with bovine serum
albumin as standard.
Mitochondria (0.125 mg protein) were incubated in plastic 1.5 ml
tubes in a ¢nal volume of 500 Wl of respiration bu¡er containing
sucrose (25 mM), mannitol (75 mM), KCl (199 mM), Tris-phosphate
(10 mM), fat-free BSA (1 mg/ml), glutamate (10 mM), malate (2.5
mM) and ADP (5 mM). Optionally present was KCN (2 mM). NOc
solution (1 Wl, ¢nal concentration 4 WM) or degraded NOc were added
after 3 min and incubations allowed to run for a maximum of 15 min,
mixing and aerating tubes every 3 min. A time course was constructed
by performing individual incubations for each time point.
At the end of incubations, reactions were quenched by the addition
of 10% perchloric acid (125 Wl) to each tube, mixing, addition of 1 M
KH2PO4 (200 Wl), mixing and immediate transfer of the tube to liquid
N2. Samples were stored at 380‡C (6 2 days) and analysis of the
ATP content was performed by luminometry [16]. No signi¢cant deg-
radation of ATP occurred over the storage period.
Cytochrome c was reduced by incubation with ascorbate, then pu-
ri¢ed using a gel ¢ltration column (Pharmacia PD-10). Wavelength
spectra were obtained using a Uvikon 930 spectrophotometer (Kon-
tron Instruments). Reduced cytochrome c was incubated at 20 WM in
10 mM phosphate bu¡er (equilibrated with the air), pH 7.2, with a
single addition of NOc solution (¢nal concentration 80 WM).
3. Results
Fig. 1 shows the e¡ects of NOc, degraded NOc and KCN on
rat brain mitochondrial ATP synthesis. Addition of NOc
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(4 WM) at 3 min caused a rapid inhibition of the ATP syn-
thesis. After a further 7^12 min, the rate of ATP synthesis had
recovered to 72% of the control rate (no NOc). Degraded NOc
had no e¡ect on the mitochondrial ATP synthesis. Addition
of KCN (2 mM) at 3 min caused a rapid irreversible inhib-
ition of the ATP production. This inhibition was not amelio-
rated by co-addition of NOc at the same time as KCN.
Fig. 2 shows the e¡ects of NOc exposure on the wavelength
spectra of initially reduced cytochrome c. The addition of NOc
(80 WM) caused a decrease in the peak at 550 nm, indicating
oxidation of cytochrome c. Sequential additions of intermedi-
ate concentrations of NOc caused intermediate reductions in
the peak at 550 nm (data omitted for clarity).
4. Discussion
The recent surge for publications regarding reversible inhib-
ition of mitochondrial oxygen consumption by NOc [3^12],
together with the reported discovery of a putative NOc syn-
thase activity in mitochondria [17^21] has led to the common
assumption that NOc may be a physiological regulator of
cellular energy metabolism. However, most NOc inhibition
studies in mitochondria have only examined the mitochon-
drial oxygen consumption and there is no direct evidence
that NOc inhibits the mitochondrial ATP synthesis. In this
study we have used isolated brain mitochondria to investigate
the e¡ects of NOc on the mitochondrial ATP synthesis.
The results in Fig. 1 show that NOc does indeed inhibit the
mitochondrial ATP synthesis. The time course of the inhib-
ition bears remarkable similarity to that seen for NOc inhib-
ition of mitochondrial oxygen consumption [4,5,7^9,11]. De-
graded NOc had no e¡ect on the ATP synthetic rate,
suggesting the e¡ects of NOc were direct and not due to its
breakdown products.
In Fig. 2, the characteristic K peak at 550 nm in the ab-
sorption spectrum of reduced cytochrome c is decreased fol-
lowing exposure to NOc, suggesting the direct oxidation of
cytochrome by NOc or one of the products generated from
NOc under aerobic conditions, e.g. NO2 and N2O3. In respir-
ing mitochondria, such a reaction could theoretically bypass
COX, allowing continued proton pumping by complexes I
and III of the respiratory chain and continued ATP synthesis
at decreased stoichiometry. However the data in Fig. 1 show
that NOc is unable to recover any ATP synthesis in mitochon-
dria that have their cytochrome oxidase blocked by cyanide,
suggesting that such a bypass does not occur in intact mito-
chondria. In addition, the high concentrations of NOc re-
quired to bring about cytochrome c oxidation in this experi-
ment (80 WM: four times the cytochrome c concentration) are
unlikely to be encountered by cytochrome c in mitochondria
in vivo, even in pathological situations.
It is interesting to note that the NOc inhibition of mitochon-
drial ATP synthesis observed in Fig. 1 is not fully reversible
during the time course and experimental conditions studied.
Closer examination of oxygen electrode data in previously
published studies shows that oxygen consumption in mito-
chondria isolated from heart [9] and liver [7,8] and mitochon-
dria within isolated synaptosomes [3] and cultured astrocytes
[11] is also not 100% recoverable on a similar time scale.
These results taken together suggest that even at the low
NOc concentrations required to inhibit mitochondrial respira-
tion and ATP synthesis, there may be a secondary irreversible
inhibition. Clementi et al. recently reported that long term
exposure of cells to NOc leads to the irreversible inhibition
of mitochondrial complex I, which the authors suggest may be
nitrosothiol-mediated [22]. Irreversible damage to the mito-
chondrial respiratory chain may also occur as a result of per-
oxynitrite generation. It is known that mitochondria are a
source of superoxide (O2cÿ) within eukaryotic cells [23] and
it has been demonstrated that this O2cÿ may react with NOc to
make peroxynitrite (ONOOÿ) [24], which is widely reported to
cause irreversible damage to mitochondria [9,14,24^27].
In summary we have shown here that, as previously as-
sumed from indirect evidence, NOc inhibits the mitochondrial
ATP synthesis. This inhibition is not fully reversible and the
irreversible portion may theoretically involve ONOOÿ. Thus,
it is reasonable to assume that in pathological conditions in
which overproduction of NOc is thought to play a role, cel-
lular energy metabolism and functions that rely on ATP may
be compromised. Such e¡ects may be of particular relevance
to tissues such as the brain that rely heavily on oxidative
phosphorylation for their energy requirements.
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Fig. 1. The e¡ects of NOc on rat brain mitochondrial ATP synthe-
sis. Mitochondria were incubated at 0.25 mg protein/ml as detailed
in Section 2 (b) with the following additions after 3 min (as indi-
cated by arrow): 4 WM NOc (F), degraded NOc (E), 2 mM KCN
(R) and KCN plus NOb (v). Data are means þ S.E.M. of 5 inde-
pendent experiments.
Fig. 2. Absorbance spectrum of cytochrome c (20 WM). A: fully re-
duced form, B: following addition of NOc (80 WM). Spectra were
measured as detailed in Section 2.
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